On June 1, CannDelta became the Official Regulatory Advisory of Business of Cannabis. We also announced that on a weekly basis, CannDelta will participate in an “Ask the Experts” segment that seeks to answer pressing questions posed through the BofC platform. This is the first segment of Ask the Experts – and Sherry Boodram, PhD will be on BofC Live to answer the first question.
Learn more about Sherry Boodram and CannDelta.
Listen to this episode as a podcast.
The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.
As the excitement around President Donald Trump's executive order to push forward with cannabis rescheduling has faded, the bill is...
President Donald Trump's executive order directing federal agencies to move cannabis from Schedule I to Schedule III of the Controlled...
Event
Europe’s leading cannabis policy, business and investment conference — bringing senior decision-makers together in Paris.
President Donald Trump's executive order directing federal agencies to move cannabis from Schedule I to Schedule III of the Controlled...
After two years of speculation, rumours, stock swings, broken promises, and political theatre, President Donald Trump officially signed an executive...
Cannabis Rescheduling fervour has once again reached dramatic levels following media reports that President Donald Trump is considering pushing through...
After a broadly optimistic and reform-driven 2024, this year saw momentum beging to shift once again for the global cannabis...
Business of Cannabis: New York 2025 arrived at a crucial moment not just for the local cannabis industry, but for...
Sorting Evidence from Anecdote As global cannabis research accelerates, the number of published studies has never been higher, but not...
Cannabis is now one of the most frequently discussed therapeutic agents in modern medicine, driven by expanding access programmes and...
The incomprehensible economic strategy of President Trump’s global tariffs has left almost every US industry scratching their heads, and fearing...
Canada has officially introduced a raft of regulatory updates to its cannabis laws, marking the most significant shift in policy...
Canada’s health regulator has announced plans to establish a regulatory framework enabling CBD products to be sold over the counter...
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
